Agenus maintains a global footprint by collaborations and partnerships with leading pharmaceutical and biotechnology firms in North The us, Europe and Asia. Its agreements include things like investigation and development collaborations, license preparations and co-progress systems aimed at accelerating the translation of novel immunotherapies into